Illuminating neuromyelitis optica pathogenesis
- PMID: 22308524
- PMCID: PMC3268276
- DOI: 10.1073/pnas.1119288109
Illuminating neuromyelitis optica pathogenesis
Conflict of interest statement
The author declares no conflict of interest.
Comment on
-
Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes.Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1245-50. doi: 10.1073/pnas.1109980108. Epub 2011 Nov 29. Proc Natl Acad Sci U S A. 2012. PMID: 22128336 Free PMC article.
References
-
- Lennon VA, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet. 2004;364:2106–2112. - PubMed
-
- Cree BA, Goodin DS, Hauser SL. Neuromyelitis optica. Semin Neurol. 2002;22:105–122. - PubMed
-
- Weinshenker BG. Clinical overview of neuromyelitis optica. Rinsho Shinkeigaku. 2009;49:894–895. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
